EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark BIFIASTHM was filed as Word mark on 05/24/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/05/2016.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 015468598 |
| Application date | May 24, 2016 |
| Publication date | August 26, 2016 |
| Entry date | December 5, 2016 |
| Expiration date | May 24, 2026 |
Trademark owner
Via Mattei, 3
28100 Novara (NO)
IT
28100 Novara (NO)
IT
Trademark representatives
Via Larga 16
20122 Milano (MI)
IT
goods and services
5
Pharmaceutical preparations, in particular pharmaceutical preparations for the treatment of inflammatory diseases, inflammatory diseases of the respiratory tract, respiratory disorders, diseases and infections of the respiratory tract, allergies and asthma; Pharmaceutical preparations, in particular pharmaceutical preparations containing microorganisms, probiotic microorganisms' cultures, enzymes, probiotic bacterial formulations, lactic bacteria and bifidobacteria for the treatment of inflammatory diseases, inflammatory diseases of the respiratory tract, respiratory disorders, diseases and infections of the respiratory tract, allergies and asthma; Dietetic substances and dietetic foods adapted for medical use, food for babies; Dietetic substances and dietetic foods adapted for medical use, in particular for the treatment of inflammatory diseases, inflammatory diseases of the respiratory tract, respiratory disorders, diseases and infections of the respiratory tract, allergies and asthma; Dietetic substances and dietetic foods adapted for medical use, in particular containing microorganisms, probiotic microorganisms' cultures, enzymes, probiotic bacterial formulations, lactic bacteria and bifidobacteria for the treatment of inflammatory diseases, inflammatory diseases of the respiratory tract, respiratory disorders, diseases and infections of the respiratory tract, allergies and asthma; Dietary supplements for humans; Dietary supplements and dietetic food supplements adapted for medical purposes; Dietary supplements and dietetic food supplements adapted for medical purposes, in particular for the treatment of inflammatory diseases, inflammatory diseases of the respiratory tract, respiratory disorders, diseases and infections of the respiratory tract, allergies and asthma; Dietary supplements and dietetic food supplements adapted for medical purposes, in particular containing microorganisms, probiotic microorganisms' cultures, enzymes, probiotic bacterial formulations, lactic bacteria and bifidobacteria for the treatment of inflammatory diseases, inflammatory diseases of the respiratory tract, respiratory disorders, diseases and infections of the respiratory tract, allergies and asthma; Drinks for medicinal purposes, dietetic beverages adapted for medical purposes and dietary supplemental drinks; Dietetic and nutritional supplements, vitamin preparations, in particular dietetic and nutritional supplements, vitamin preparations containing microorganisms, probiotic microorganisms' cultures, enzymes, probiotic bacterial formulations, lactic bacteria and bifidobacteria; Dietary food supplements, in particular dietary food supplements containing microorganisms, probiotic microorganisms' cultures, enzymes, probiotic bacterial formulations, lactic bacteria and bifidobacteria; Food supplements, in particular dietary food supplements containing microorganisms, probiotic microorganisms' cultures, enzymes, probiotic bacterial formulations, lactic bacteria and bifidobacteria; Food supplements and dietetic substances, in particular dietary food supplements containing microorganisms, probiotic microorganisms' cultures, enzymes, probiotic bacterial formulations, lactic bacteria and bifidobacteria
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| February 11, 2022 | Change Representative, Published | ||
| September 12, 2018 | Change Representative, Published |
ID: 11015468598